Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences.

Oncology reports - 1 Jan 2000

Dahse Regine, Gärtner Daniela, Werner Wolfram, Schubert Jörg, Junker Kerstin

Abstract excerpt

The clonality of synchronous and metachronous bladder tumors has been studied for years with controversial results. Some recent studies support the 'polyclonal origin' hypothesis, i.e. that independently transformed different tumor cell clones exist in the same bladder cancer patient and arise fr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Transitional Cell
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Genes, p53

Share to Mutagens

Share to Recurrence

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 14534739

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14534739-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences.PMID 14534739Read ↗

Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer.Semantic proximity Read ↗

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studiesSemantic proximity Read ↗

Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study.Semantic proximity Read ↗

Oligoclonality in Bladder Cancer:: The Implication for Molecular TherapiesSemantic proximity Read ↗

Molecular Determinants of Tumor Recurrence in The Urinary BladderSemantic proximity Read ↗

Origin of multifocal carcinomas of the bladder and upper urinary tract: Molecular analysis and clinical implicationsSemantic proximity Read ↗

Determining the origin of synchronous multifocal bladder cancer by exome sequencing.Semantic proximity Read ↗

Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract.Semantic proximity Read ↗

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.Semantic proximity Read ↗

Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation analysis.Semantic proximity Read ↗

Molecular evolution of multiple recurrent cancers of the bladder.Semantic proximity Read ↗

Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.